Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(60.0%)
Phase 3
1(20.0%)
Phase 4
1(20.0%)
5Total
N/A(3)
Phase 3(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06753500Phase 4Recruiting

Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy

Role: lead

NCT06137924Phase 3Unknown

Intraoperative Autonomic Neural Blockade

Role: lead

NCT05668845Not ApplicableCompleted

Paragastric Autonomic Neural Blockade as Part of Combined Anesthesia.

Role: lead

NCT05353426Not ApplicableCompleted

Paragastric Autonomic Blockade to Prevent Visceral Pain After Laparoscopic Sleeve Gastrectomy

Role: lead

NCT03721185Not ApplicableCompleted

Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment

Role: collaborator

All 5 trials loaded